Royal London Asset Management Ltd. acquired a new stake in HCA Healthcare Inc (NYSE:HCA) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 124,583 shares of the company’s stock, valued at approximately $12,780,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Smithfield Trust Co. raised its stake in HCA Healthcare by 541.9% in the 2nd quarter. Smithfield Trust Co. now owns 995 shares of the company’s stock valued at $102,000 after purchasing an additional 840 shares during the last quarter. Signet Financial Management LLC acquired a new position in HCA Healthcare in the 2nd quarter valued at $137,000. Adviser Investments LLC acquired a new position in HCA Healthcare in the 2nd quarter valued at $159,000. Bridgeworth LLC acquired a new position in HCA Healthcare in the 2nd quarter valued at $173,000. Finally, Hyman Charles D acquired a new position in HCA Healthcare in the 2nd quarter valued at $205,000. 70.37% of the stock is owned by hedge funds and other institutional investors.

Several research analysts recently commented on the company. ValuEngine downgraded HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Thursday, June 28th. Jefferies Financial Group upped their target price on HCA Healthcare to $155.00 and gave the company a “buy” rating in a report on Friday. Robert W. Baird upped their target price on HCA Healthcare from $130.00 to $150.00 and gave the company a “positive” rating in a report on Thursday. SunTrust Banks upped their target price on HCA Healthcare to $145.00 and gave the company a “buy” rating in a report on Thursday, July 26th. Finally, Barclays initiated coverage on HCA Healthcare in a report on Tuesday, August 14th. They issued an “overweight” rating and a $150.00 target price for the company. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and eighteen have given a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $131.62.

NYSE HCA opened at $133.37 on Friday. The firm has a market cap of $46.15 billion, a PE ratio of 20.24, a price-to-earnings-growth ratio of 1.20 and a beta of 0.54. The company has a debt-to-equity ratio of -7.64, a current ratio of 1.36 and a quick ratio of 1.15. HCA Healthcare Inc has a twelve month low of $71.18 and a twelve month high of $138.18.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Wednesday, July 25th. The company reported $2.29 earnings per share for the quarter, topping analysts’ consensus estimates of $2.16 by $0.13. The business had revenue of $11.53 billion during the quarter, compared to analysts’ expectations of $11.32 billion. HCA Healthcare had a negative return on equity of 61.68% and a net margin of 6.21%. The company’s revenue was up 7.4% compared to the same quarter last year. During the same period in the prior year, the business posted $1.73 EPS. equities analysts expect that HCA Healthcare Inc will post 9.23 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 28th. Stockholders of record on Tuesday, September 4th will be issued a dividend of $0.35 per share. This represents a $1.40 dividend on an annualized basis and a dividend yield of 1.05%. The ex-dividend date is Friday, August 31st. HCA Healthcare’s dividend payout ratio is presently 21.24%.

In other news, SVP Jane D. Englebright sold 6,543 shares of the stock in a transaction on Wednesday, August 15th. The stock was sold at an average price of $129.86, for a total transaction of $849,673.98. Following the completion of the transaction, the senior vice president now directly owns 7,443 shares in the company, valued at approximately $966,547.98. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Jonathan B. Perlin sold 83,298 shares of the stock in a transaction on Friday, July 27th. The stock was sold at an average price of $122.00, for a total value of $10,162,356.00. Following the transaction, the insider now owns 105,394 shares of the company’s stock, valued at $12,858,068. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 170,257 shares of company stock valued at $21,118,053. Company insiders own 2.80% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Story: How Do You Calculate Return on Investment (ROI)?

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.